The Precision Peptide CoPNGAF -1.93%21 Current Ratio is 1.71 as of Jan. 2026, which is 33% above its 10-year median of 1.29. GuruFocus rates PNGAF with a GF Score™ of 21/100. The stock has 4 warning signs investors should review. Among 1,988 Consumer Packaged Goods companies, The Precision Peptide Co ranks worse than 51.26% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. The Precision Peptide Co's current ratio for the quarter that ended in Jan. 2026 was 1.71.
The Precision Peptide Co has a current ratio of 1.71. It generally indicates good short-term financial strength.
The historical rank and industry rank for The Precision Peptide Co's Current Ratio or its related term are showing as below:
PNGAF'
s Current Ratio Range Over the Past 10 Years
Min: 0.12 Med: 1.29 Max: 11.17
Current: 1.7
During the past 5 years, The Precision Peptide Co's highest Current Ratio was 11.17. The lowest was 0.12. And the median was 1.29.
PNGAF's Current Ratio is ranked worse than 51.26% of 1988
companies
in the Consumer Packaged Goods industry
Industry Median: 1.73
vs PNGAF: 1.70
The Precision Peptide Co (OTCPK:PNGAF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
The Precision Peptide Co Current Ratio Related Terms
The Precision Peptide Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, The Precision Peptide Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Precision Peptide Co Current Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, The Precision Peptide Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where The Precision Peptide Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Precision Peptide Co (PNGAF) has a Current Ratio of 1.71 as of Jan. 2026. This is 33% above median its historical median of 1.29. Over the past decade, The Precision Peptide Co's Current Ratio has ranged from 0.12 to 11.17. According to the industry distribution chart, The Precision Peptide Co ranks #1019 out of 1988 companies in the Consumer Packaged Goods industry, placing it in the top 51.3%.
Is The Precision Peptide Co's Current Ratio too high?
The Precision Peptide Co's current Current Ratio of 1.71 is 33% above median its 10-year median of 1.29. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 11.17. The Consumer Packaged Goods industry median Current Ratio is 1.73. The Precision Peptide Co's value of 1.71 is 1.2% below this industry median. Based on the distribution chart, The Precision Peptide Co ranks #1019 out of 1988 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, The Precision Peptide Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's Current Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, The Precision Peptide Co ranks #1019 out of 1988 companies for Current Ratio. This places The Precision Peptide Co in the lower half of its industry. The industry median Current Ratio is 1.73. The Precision Peptide Co's value of 1.71 is 1.2% below this benchmark. Historically, The Precision Peptide Co's own Current Ratio has ranged from 0.12 to 11.17 over the past decade. While the company's 10-year median is 1.29 vs. the industry median of 1.73, The Precision Peptide Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Consumer Packaged Goods company?
The median Current Ratio among Consumer Packaged Goods companies is 1.73, based on 1,988 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Precision Peptide Co's current Current Ratio of 1.71 is 1.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median Current Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Precision Peptide Co's current Current Ratio is 1.71, which is 33% above median its own 10-year median of 1.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current Current Ratio of 1.71. The current Current Ratio is 1.71, which is 33% above median its 10-year median of 1.29 and 1.2% below the Consumer Packaged Goods industry median of 1.73. The Precision Peptide Co's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current Current Ratio is 1.71 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
21GF Score
Get the complete analysis for PNGAF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PNGAF has been successfully added to your 
